My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bicycle Therapeutics plc - American Depositary Shares (NQ:BCYC)

7.540 -0.040 (-0.53%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 377,826
Open 7.510
Bid (Size) 7.500 (13)
Ask (Size) 7.550 (10)
Prev. Close 7.580
Today's Range 7.400 - 7.780
52wk Range 6.100 - 28.67
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bicycle Therapeutics Strengthens Board of Directors with New Appointments
From Bicycle Therapeutics plc
Via Business Wire
4 Analysts Assess Bicycle Therapeutics: What You Need To Know
 
Via Benzinga

Performance

YTD
-47.5%
-47.5%
1 Month
+5.9%
+5.9%
3 Month
+6.2%
+6.2%
6 Month
-13.6%
-13.6%
1 Year
-68.1%
-68.1%

More News

Read More
Bicycle (BCYC) Q2 Revenue Falls 69%
Via The Motley Fool
Topics Intellectual Property
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
From Bicycle Therapeutics plc
Via Business Wire
Deep Dive Into Bicycle Therapeutics Stock: Analyst Perspectives (9 Ratings)
Via Benzinga
Forecasting The Future: 11 Analyst Projections For Bicycle Therapeutics
Via Benzinga
Demystifying Bicycle Therapeutics: Insights From 7 Analyst Reviews
Via Benzinga
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting
From Bicycle Therapeutics
Via Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Bicycle Therapeutics plc
Via Business Wire
A Glimpse Into The Expert Outlook On Bicycle Therapeutics Through 7 Analysts
Via Benzinga
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025
From Bicycle Therapeutics plc
Via Business Wire
Analyst Expectations For Bicycle Therapeutics's Future
Via Benzinga
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Bicycle Therapeutics plc
Via Business Wire

Frequently Asked Questions

Is Bicycle Therapeutics plc - American Depositary Shares publicly traded?
Yes, Bicycle Therapeutics plc - American Depositary Shares is publicly traded.
What exchange does Bicycle Therapeutics plc - American Depositary Shares trade on?
Bicycle Therapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Bicycle Therapeutics plc - American Depositary Shares?
The ticker symbol for Bicycle Therapeutics plc - American Depositary Shares is BCYC on the Nasdaq Stock Market
What is the current price of Bicycle Therapeutics plc - American Depositary Shares?
The current price of Bicycle Therapeutics plc - American Depositary Shares is 7.540
When was Bicycle Therapeutics plc - American Depositary Shares last traded?
The last trade of Bicycle Therapeutics plc - American Depositary Shares was at 09/25/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.